Sekisui Chemical Co's Days Sales Outstanding for the
three
months ended in Mar. 2026 was 55.08.
Sekisui Chemical Co's Days Inventory for the
three
months ended in Mar. 2026 was 135.62.
Sekisui Chemical Co's Days Payable for the
three
months ended in Mar. 2026 was 41.32.
Therefore, Sekisui Chemical Co's Cash Conversion Cycle (CCC) for the
three
months ended in Mar. 2026 was 149.38.
Sekisui Chemical Co (FRA:SUI) Cash Conversion Cycle Explanation
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Sekisui Chemical Co Cash Conversion Cycle Related Terms
Sekisui Chemical Co Cash Conversion Cycle Historical Data
* Premium members only.
The historical data trend for Sekisui Chemical Co's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:SUI vs HON, MMM: Cash Conversion Cycle Comparison
For the Conglomerates subindustry, Sekisui Chemical Co's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sekisui Chemical Co Cash Conversion Cycle vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, Sekisui Chemical Co's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Sekisui Chemical Co's Cash Conversion Cycle falls into.
Sekisui Chemical Co Cash Conversion Cycle Calculation
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
Sekisui Chemical Co's Cash Conversion Cycle for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sekisui Chemical Co (FRA:SUI) has a Cash Conversion Cycle of 149.38 as of Mar. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Sekisui Chemical Co and its competitors.
Is Sekisui Chemical Co's Cash Conversion Cycle too high?
Sekisui Chemical Co's current Cash Conversion Cycle is 149.38. The Conglomerates industry median Cash Conversion Cycle is 70.95. Sekisui Chemical Co's value of 149.38 is 110.6% above this industry median. Overall, Sekisui Chemical Co has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sekisui Chemical Co's Cash Conversion Cycle compare to HON and MMM?
Sekisui Chemical Co's Cash Conversion Cycle of 149.38 can be compared against companies in the Conglomerates industry. The industry median Cash Conversion Cycle is 70.95. Sekisui Chemical Co's value of 149.38 is 110.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Conglomerates company?
The median Cash Conversion Cycle among Conglomerates companies is 70.95, based on 546 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sekisui Chemical Co's current Cash Conversion Cycle of 149.38 is 110.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Sekisui Chemical Co and its competitors. For the Conglomerates industry, the median Cash Conversion Cycle is 70.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sekisui Chemical Co's current Cash Conversion Cycle is 149.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sekisui Chemical Co stock overvalued right now?
Based on GuruFocus' analysis, Sekisui Chemical Co (FRA:SUI) is currently considered Fairly Valued. The stock's GF Value™ is €13.40, compared to a current price of €13.80 — trading 3% above its estimated fair value. The current Cash Conversion Cycle is 149.38 and 110.6% above the Conglomerates industry median of 70.95. Sekisui Chemical Co's overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Sekisui Chemical Co (FRA:SUI), the current Cash Conversion Cycle is 149.38 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sekisui Chemical Co (FRA:SUI) Overvalued in 2026?
Based on GuruFocus' analysis, Sekisui Chemical Co stock appears to be overvalued.
The current stock price of €13.80 is trading 3% above its estimated GF Value™ of €13.40.
GuruFocus considers Sekisui Chemical Co to be Fairly Valued.
Key valuation signals for FRA:SUI:
Cash Conversion Cycle: 149.38
GF Value™: €13.40 vs. price of €13.80 (3% above fair value)
Industry Position: 110.6% above the Conglomerates median
No single metric tells the full story. See the FRA:SUI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sekisui Chemical Co Ltd is a Japanese diversified holding company engaged in the housing, infrastructure, high-performance plastics, and medical businesses. The company operates through four segments: Housing, which handles the manufacture, sale, and renovation of unit housing and real estate services; Environment & Lifeline, which produces and sells plastic pipes, building materials, and infrastructure products; High Performance Plastics, which manufactures glass interlayer films, polyolefin foams, adhesive tapes, and functional materials; and Medical, which produces and sells diagnostic reagents, medical raw materials, and pharmaceutical intermediates. It generates the majority of its revenue from the Housing segment.
76GF Score
Get the complete analysis for FRA:SUI
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:SUI has been successfully added to your 
